v3.26.1
CONDENSED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Restricted stock units
Total Shareholders' Equity
Total Shareholders' Equity
Stock Options and Stock Appreciation Rights
Total Shareholders' Equity
Performance share awards
Total Shareholders' Equity
Restricted stock units
Common Stock
Common Stock
Stock Options and Stock Appreciation Rights
Common Stock
Performance share awards
Common Stock
Restricted stock units
Additional Paid-In Capital
Additional Paid-In Capital
Stock Options and Stock Appreciation Rights
Additional Paid-In Capital
Performance share awards
Additional Paid-In Capital
Restricted stock units
Retained Earnings
Treasury Shares- at Cost
Treasury Shares- at Cost
Stock Options and Stock Appreciation Rights
Treasury Shares- at Cost
Performance share awards
Treasury Shares- at Cost
Restricted stock units
Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Jun. 30, 2024             38,409                          
Beginning balance at Jun. 30, 2024     $ 1,688,781       $ 10,000       $ 193,778       $ 2,121,838 $ (559,269)       $ (77,566)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                        
Net income     92,063                       92,063          
Other comprehensive loss (income)     (8,942)                                 (8,942)
Cash dividends     (9)                       (9)          
Purchases of common stock for treasury (in Shares)             (52)                          
Purchases of common stock for treasury     (10,479)                         (10,479)        
Treasury shares issued for:                                        
Exercise of stock appreciation rights (in shares)               19                        
Additional Paid in Capital, Exercise of stock appreciation rights, Performance share awards, Restricted stock units                       $ (1,106) $ (2,213) $ (2,123)            
Exercise of stock appreciation rights                                 $ (1,339)      
Treasury shares issued for total shareholders' equity       $ (2,445) $ (5,507) $ (4,259)                            
Performance share awards (in shares)                 34                      
Performance share awards                                   $ (3,294)    
Restricted stock units (in shares)                   37                    
Restricted stock units                                     $ (2,136)  
Compensation expense     1,675 1,326             1,675 1,326                
Other (in shares)             (1)                          
Other     (127)               (12)       (24) (91)        
Ending balance (in shares) at Sep. 30, 2024             38,446                          
Ending balance at Sep. 30, 2024     1,752,077       $ 10,000       191,325       2,213,868 (576,608)       (86,508)
Beginning balance (in shares) at Jun. 30, 2024             38,409                          
Beginning balance at Jun. 30, 2024     1,688,781       $ 10,000       193,778       2,121,838 (559,269)       (77,566)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                        
Net income $ 285,152                                      
Other comprehensive loss (income) (29,196)                                     (29,196)
Ending balance (in shares) at Mar. 31, 2025             38,188                          
Ending balance at Mar. 31, 2025     1,827,481       $ 10,000       196,610       2,375,017 (647,384)       (106,762)
Beginning balance (in shares) at Sep. 30, 2024             38,446                          
Beginning balance at Sep. 30, 2024     1,752,077       $ 10,000       191,325       2,213,868 (576,608)       (86,508)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                        
Net income     93,290                       93,290          
Other comprehensive loss (income)     (19,326)                                 (19,326)
Cash dividends     (14,253)                       (14,253)          
Purchases of common stock for treasury (in Shares)             (75)                          
Purchases of common stock for treasury     (20,103)                         (20,103)        
Treasury shares issued for:                                        
Exercise of stock appreciation rights (in shares)               6                        
Additional Paid in Capital, Exercise of stock appreciation rights, Performance share awards, Restricted stock units                       (321)                
Exercise of stock appreciation rights                                 (402)      
Treasury shares issued for total shareholders' equity       (723)                                
Compensation expense     1,426 1,127             1,426 1,127                
Other     (3)                       (3)          
Ending balance (in shares) at Dec. 31, 2024             38,377                          
Ending balance at Dec. 31, 2024     1,793,512       $ 10,000       193,557       2,292,902 (597,113)       (105,834)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                        
Net income 99,799   99,799                       99,799          
Other comprehensive loss (income) (928)   (928)                                 (928)
Cash dividends     (17,683)                       (17,683)          
Purchases of common stock for treasury (in Shares)             (205)                          
Purchases of common stock for treasury     (49,765)                         (49,765)        
Treasury shares issued for:                                        
Exercise of stock appreciation rights (in shares)               8                        
Additional Paid in Capital, Exercise of stock appreciation rights, Performance share awards, Restricted stock units                       (495)   (118)            
Exercise of stock appreciation rights                                 (739)      
Treasury shares issued for total shareholders' equity       (1,234)   (61)                            
Restricted stock units (in shares)                   3                    
Restricted stock units                                     57  
Compensation expense     2,723 1,117             2,723 1,117                
Other (in shares)             5                          
Other     1               (174)       (1) 176        
Ending balance (in shares) at Mar. 31, 2025             38,188                          
Ending balance at Mar. 31, 2025     1,827,481       $ 10,000       196,610       2,375,017 (647,384)       (106,762)
Beginning balance (in shares) at Jun. 30, 2025             37,868                          
Beginning balance at Jun. 30, 2025 1,844,520   1,844,520       $ 10,000       198,970       2,447,931 (720,695)       (91,686)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                        
Net income     100,807                       100,807          
Other comprehensive loss (income)     (1,889)                                 (1,889)
Purchases of common stock for treasury (in Shares)             (204)                          
Purchases of common stock for treasury     (53,566)                         (53,566)        
Treasury shares issued for:                                        
Exercise of stock appreciation rights (in shares)               15                        
Additional Paid in Capital, Exercise of stock appreciation rights, Performance share awards, Restricted stock units                       (1,098) $ (1,942) (1,013)            
Exercise of stock appreciation rights                                 (1,270)      
Treasury shares issued for total shareholders' equity       (2,368) $ (4,847) $ (2,145)                            
Performance share awards (in shares)                 25                      
Performance share awards                                   $ (2,905)    
Restricted stock units (in shares)                   14                    
Restricted stock units                                     (1,132)  
Compensation expense     1,831 1,494             1,831 1,494                
Other     (82)               (1)       53 (134)        
Ending balance (in shares) at Sep. 30, 2025             37,718                          
Ending balance at Sep. 30, 2025     1,883,755       $ 10,000       198,241       2,548,791 (779,702)       (93,575)
Beginning balance (in shares) at Jun. 30, 2025             37,868                          
Beginning balance at Jun. 30, 2025 1,844,520   1,844,520       $ 10,000       198,970       2,447,931 (720,695)       (91,686)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                        
Net income 295,925                                      
Other comprehensive loss (income) (3,836)                                     (3,836)
Ending balance (in shares) at Mar. 31, 2026             37,055                          
Ending balance at Mar. 31, 2026 1,860,043   1,860,043       $ 10,000       202,368       2,707,720 (964,523)       (95,522)
Beginning balance (in shares) at Sep. 30, 2025             37,718                          
Beginning balance at Sep. 30, 2025     1,883,755       $ 10,000       198,241       2,548,791 (779,702)       (93,575)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                        
Net income     95,349                       95,349          
Other comprehensive loss (income)     1,244                                 1,244
Cash dividends     (17,306)                       (17,306)          
Purchases of common stock for treasury (in Shares)             (347)                          
Purchases of common stock for treasury     (89,807)                         (89,807)        
Treasury shares issued for:                                        
Exercise of stock appreciation rights (in shares)               13                        
Additional Paid in Capital, Exercise of stock appreciation rights, Performance share awards, Restricted stock units                       (897)   $ (19)            
Exercise of stock appreciation rights                                 (764)      
Treasury shares issued for total shareholders' equity       (1,661)                                
Restricted stock units (in shares)                   1                    
Restricted stock units   $ 0                                 $ 19  
Compensation expense     1,449 1,393             1,449 1,393                
Other (in shares)             (1)                          
Other     (8)               1       (7) (2)        
Ending balance (in shares) at Dec. 31, 2025             37,384                          
Ending balance at Dec. 31, 2025     1,874,408       $ 10,000       200,168       2,626,827 (870,256)       (92,331)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                        
Net income 99,769   99,769                       99,769          
Other comprehensive loss (income) (3,191)   (3,191)                                 (3,191)
Cash dividends     (19,004)                       (19,004)          
Purchases of common stock for treasury (in Shares)             (346)                          
Purchases of common stock for treasury     (93,864)                         (93,864)        
Treasury shares issued for:                                        
Exercise of stock appreciation rights (in shares)               13                        
Additional Paid in Capital, Exercise of stock appreciation rights, Performance share awards, Restricted stock units                       (978)                
Exercise of stock appreciation rights                                 $ (642)      
Treasury shares issued for total shareholders' equity       (1,620)                                
Compensation expense     2,134 $ 1,287             2,134 $ 1,287                
Other (in shares)             4                          
Other     124               (243)       128 239        
Ending balance (in shares) at Mar. 31, 2026             37,055                          
Ending balance at Mar. 31, 2026 $ 1,860,043   $ 1,860,043       $ 10,000       $ 202,368       $ 2,707,720 $ (964,523)       $ (95,522)